Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-03-28Clinical Trial Update: Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome
This clinical trial update discusses the timing of optimal platelet inhibition after acute coronary syndrome, sponsored by Hôpital de la Tim…
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT [Phase 2]
Phase 2 randomized trial comparing the Combo Stent from OrbusNeich to an everolimus-eluting stent in acute coronary syndrome, assessed with …
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Antithrombotic Triple Therapy in Humans [Phase 4]
A Phase 4 study evaluating antithrombotic triple therapy in patients with atrial fibrillation and acute coronary syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: The Israeli MGuard Registry
The Israeli MGuard Registry, sponsored by InspireMD, has completed a clinical trial evaluating the MGuard stent system for conditions includ…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes [Phase 2]
Phase 2 FRANCIS-ACS trial evaluating A 002 for safety and efficacy in acute coronary syndromes has completed. The sponsor is Anthera Pharmac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-03-04FDA Approved: CLOPIDOGREL — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original generic application for clopidogrel bisulfate (clopidogrel).
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial [Phase 2]
Phase 2 CHI SQUARE trial evaluated CER-001 for efficacy and safety in patients with acute coronary syndrome and atherosclerosis. The study h…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction [Phase 3]
This Phase 3 trial compares prasugrel administration at PCI versus at diagnosis in non-ST-elevation acute coronary syndromes. The study is c…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®) [Phase 4]
Phase 4 trial comparing generic versus original clopidogrel bisulfate for platelet inhibition after loading in acute coronary syndrome, usin…
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Identification of Clopidogrel CYP2C19 Metabolizer and Thienopyridine Treatment After an Acute Coronary Syndrome
The completed trial investigates CYP2C19 metabolizer status and its implications for clopidogrel (a thienopyridine) therapy after an acute c…
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome [Phase 4]
Phase 4 trial evaluating early effects of intensive lipid lowering with ezetimibe/simvastatin (Vytorin) on plaque characteristics in acute c…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor . [Phase 4]
Phase 4 clinical trial comparing loading doses of prasugrel vs ticagrelor in acute coronary syndrome patients undergoing percutaneous corona…
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel [Phase 4]
A Phase 4 clinical trial comparing loading doses of ticagrelor versus clopidogrel in acute coronary syndrome patients undergoing percutaneou…
-
CLINICAL_TRIALS research · 2014-01-08Clinical Trial Update: Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII [Phase 4]
A Phase IV clinical trial update comparing TiTAN2 and COBALT-CHROME coronary stents assessing efficacy and safety in patients with acute cor…
-
CLINICAL_TRIALS research · 2014-01-08Clinical Trial Update: "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER- [Phase 4]
Phase 4 clinical trial comparing pharmacodynamic effects of omeprazole versus pantoprazole on platelet reactivity in patients with acute cor…
-
FDA approval · 2013-12-12FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS research · 2013-12-09Clinical Trial Update: Incidence and Prognostic Value of DELIRIUM in Patients With Acute CORonary synDrome: an observatIonal Study
This clinical trial update describes an observational study on the incidence of delirium in patients with acute coronary syndrome. It also i…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Perioperative Management of Patients With Coronary Stents Undergoing Noncardiac Surgery
This clinical trial update reports completion and results posting for a study on perioperative management of patients with coronary stents u…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Low Rate Fluoroscopy to Reduce Radiation Dose During Coronary Angiography and Intervention [NA]
An update on a study evaluating low-rate fluoroscopy to reduce radiation exposure during coronary angiography and intervention in patients w…
-
CLINICAL_TRIALS research · 2013-11-25Clinical Trial Update: Clopidogrel Pharmacogenetic Score System
Clinical trial update on a pharmacogenetic scoring system to guide clopidogrel therapy in patients with acute coronary syndrome.
-
CLINICAL_TRIALS research · 2013-11-25Clinical Trial Update: Platelet Function in Patients With an Acute Coronary Syndrome
A clinical trial update focused on platelet function in patients with acute coronary syndrome; the current status is not specified.
-
FDA approval · 2013-11-19FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for EFFIENT (prasugrel hydrochloride) filed by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Ankle-Brachial Index Estimating Cardiac Complications After Surgery
Clinical trial results show that the ankle-brachial index was evaluated as a predictor of cardiovascular complications after surgery, includ…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) Study [Phase 4]
This report summarizes the results of HIROP-ACS, a Phase 4 trial evaluating high-dose pretreatment with rosuvastatin in patients with acute …
-
FDA approval · 2013-10-30FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BRILINTA (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP.